Table 3.
Patient's age |
|||
---|---|---|---|
≤18 years, N (%) |
>18 years, N (%) |
≥40 years, N (%) |
|
Total patient number (138) | 39 patients | 99 patients | 11 patients |
Stage | |||
I | 25 (64%) | 61 (62%) | 3 (27%) |
II, III, IV | 14 (36%) | 35 (35%) | 7 (64%) |
NK | 0 | 3 (3%) | 1 (9%) |
Proportions test | χ2 = 4.06, d.f. = 3, p-value = 0.12 | ||
Histology | |||
Dys | 12 (31%) | 25 (25%) | 1 (9%) |
IT (total) | 15 (38%) | 27 (27%) | 1 (9%) |
Gd 1 | 7 | 7 | 1 |
Gd 2 | 2 | 13 | 0 |
Gd 3 | 6 | 7 | 0 |
YST | 6 (15%) | 17 (17%) | 2 (18%) |
PNET | 1 | 3 | 0 |
MT | 1 | 1 | 0 |
MGCT | 4 (10%) | 26 (26%) | 7 (64%) |
Proportions test | χ2 = 4.06, d.f. = 4, p-value = 0.40 |
χ2 ,chi-squared test, d.f., degrees of freedom; Dys, dysgerminoma; IT, teratoma; YST, yolk sac tumour; MGCT, mixed germ cell tumour; PNET, primitive neuroectodermal tumour; MT, mature teratoma.